Local providers will increasingly look for help from IT firms like Indigo Biosystems Inc. and VoCare Inc. as part of a coming wave of health IT innovation that is likely to mirror the IT revolution that began 30 years ago.
Eli Lilly and Co.’s injectable form of the antipsychotic Zyprexa is being investigated by U.S. regulators after two patients died three to four days after receiving the drug.
Drug companies like Eli Lilly and Co. can be sued for paying rivals to delay low-cost versions of popular medicines, the U.S. Supreme Court said in a decision that rewrites the rules governing the release of generic drugs.
A federal lawsuit says Indiana's social services agency has made changes to Medicaid waiver programs that threaten to deprive thousands of developmentally disabled people of income they need to survive outside of institutions.
The failures raise pressure on Lilly’s experimental diabetes and cancer drugs to make it to market to offset looming patent expirations.
A new recommendation from the Medicare Payment Advisory Commission, if enacted, would likely end one of the ways Indianapolis-area hospitals have generated healthy revenue from their recent spree of physician acquisitions.
Eli Lilly and Co. will pay Canadian drug developer Transition Therapeutics Inc. at least $7 million and up to as much as $247 million to take over the development of a potential diabetes treatment.
Indiana drivers who have to show proof of insurance to police after an accident or traffic violation can do so electronically starting July 1 under a new law that signals an increasing use of technology in insurance laws.
To get control of health care spending, prominent health policy wonks are calling for new rules requiring hospitals and insurers to raise the ‘veil of secrecy’ they have thrown over their prices for decades.
The trial ended after participants showed abnormal liver biochemistry, the Indianapolis-based drugmaker said Thursday in a statement.
Starting July 1, pharmacists will be able to offer a much wider variety of immunizations to customers, in an effort from lawmakers to make health care more accessible.
Angie’s List turned a profit for the first time in nearly two decades.
After overseeing 15 years of massive growth via mergers, Vince Caponi will become an executive of St. Vincent Health’s parent organization.
While Bloomington-based medical-device maker won approval for new bile duct stent, it has recalled its hot-selling arterial stent from all global markets.
New analysis shows Obamacare would cut state’s uninsured rolls 49 percent, compared with just 18 percent if Gov. Mike Pence opts out of a Medicaid expansion.
The new not-for-profit organization is expected to be named Planned Parenthood of Indiana and Kentucky—or PPINK—and continue to operate the 28 existing health centers between the two states.
US HealthWorks Medical Group, which specializes in workers’ compensation cases, agreed in May to acquire the eight clinics. The deal is expected to close before the end of June.
Whenever a new report claims hospitals are charging too much, a stock set of defenses comes out. But hospitals are cutting prices and expenses as we speak, undermining those arguments.
The state plans to spend $37 million more each year reimbursing providers. The increase would amount to 2 percent more for hospitals, nursing facilities, home health and immediate care providers.
Marian University in Indianapolis has announced it has reached its self-imposed limit of 162 students for the incoming class of its new college of osteopathic medicine. It will be the first medical school to open in Indiana in more than 100 years.
